Evidence map›Paper›PMID 38783719›Full record

ArticleJournal of microbiology and biotechnology2024

The Metabolic Functional Feature of Gut Microbiota in Mongolian Patients with Type 2 Diabetes.

Yanchao Liu, Hui Pang, Na Li, Yang Jiao, Zexu Zhang, Qin Zhu

Abstract read
In one paragraph

Article in Journal of microbiology and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yanchao LiuDepartment of Epidemiology, School of Public Health, Inner Mongolia Medical University, Inner Mongolia Autonomous Region, Hohhot 010110, P.R. China.
Hui PangLaboratory for Molecular Epidemiology in Chronic Diseases, School of Public Health, Inner Mongolia Medical University, Inner Mongolia Autonomous Region, Hohhot 010110, P.R. China.
Na LiLaboratory for Molecular Epidemiology in Chronic Diseases, School of Public Health, Inner Mongolia Medical University, Inner Mongolia Autonomous Region, Hohhot 010110, P.R. China.
Yang JiaoCollege of Continuing Education (IMAU Branch of Educational and Training Center for Central Agricultural Cadre), Inner Mongolia Agricultural University, Inner Mongolia Autonomous Region, Hohhot 010110, P.R. China.
Zexu ZhangDepartment of Epidemiology, School of Public Health, Inner Mongolia Medical University, Inner Mongolia Autonomous Region, Hohhot 010110, P.R. China.
Qin ZhuDepartment of Epidemiology, School of Public Health, Inner Mongolia Medical University, Inner Mongolia Autonomous Region, Hohhot 010110, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The accumulating evidence substantiates the indispensable role of gut microbiota in modulating the pathogenesis of type 2 diabetes. Uncovering the intricacies of the mechanism is imperative in aiding disease control efforts. Revealing key bacterial species, their metabolites and/or metabolic pathways from the vast array of gut microorganisms can significantly contribute to precise treatment of the disease. With a high prevalence of type 2 diabetes in Inner Mongolia, China, we recruited volunteers from among the Mongolian population to investigate the relationship between gut microbiota and the disease. Fecal samples were collected from the Volunteers of Mongolia with Type 2 Diabetes group and a Control group, and detected by metagenomic analysis and untargeted metabolomics analysis. The findings suggest that

Indexed as

BacteriaDiabetes Mellitus, Type 2FecesGastrointestinal MicrobiomeAdultAgedBacillotaBacteroidetesChinaFemaleHumansMaleMetabolic Networks and PathwaysMetabolomicsMetagenomicsMiddle AgedClostridium genusgut microbiotametabolic pathwaymetabolitesMongolianType 2 diabetes

Identifiers

PMID38783719
PMCPMC11239439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.